2018 Adult Prevalence Tables
Table 7: Estimated percent using an inhaled corticosteroid in the past 3 months among adults 1 with current 2 asthma status by state/territory – BRFSS Asthma Call-back Survey, United States, 2018.
State/Territory | Current | |||
---|---|---|---|---|
Sample size± |
% | SE§ | 95% CI† | |
Arizona | 166 | 28.7 | 5.7 | (17.5 – 39.9) |
California | 221 | 31.3 | 4.1 | (23.3 – 39.3) |
Connecticut | 283 | 30.2 | 3.8 | (22.8 – 37.6) |
Florida | 461 | 27.1 | 4.9 | (17.5 – 36.7) |
Georgia | 147 | 19.2 | 4.1 | (11.2 – 27.2) |
Hawaii | 217 | 22.2 | 3.8 | (14.8 – 29.6) |
Illinois | 155 | 27.8 | 4.8 | (18.4 – 37.2) |
Indiana | 182 | 25.6 | 4.2 | (17.4 – 33.8) |
Iowa | 249 | 32.0 | 3.5 | (25.1 – 38.9) |
Kansas | 280 | 25.3 | 3.4 | (18.6 – 32.0) |
Maine | 476 | 28.7 | 3.6 | (21.6 – 35.8) |
Maryland | 297 | 35.7 | 4.3 | (27.3 – 44.1) |
Massachusetts | 180 | 38.8 | 5.6 | (27.8 – 49.8) |
Michigan | 480 | 36.0 | 2.8 | (30.5 – 41.5) |
Minnesota | 560 | 25.7 | 2.2 | (21.4 – 30.0) |
Missouri | 186 | 35.8 | 5.4 | (25.2 – 46.4) |
Montana | 151 | 30.6 | 4.9 | (21.0 – 40.2) |
Nebraska | 412 | 27.7 | 3.4 | (21.0 – 34.4) |
Nevada | 99 | 15.7 | 4.3 | (7.3 – 24.1) |
New Hampshire | 180 | 28.3 | 4.6 | (19.3 – 37.3) |
New Mexico | 204 | 37.8 | 4.8 | (28.4 – 47.2) |
New York | 313 | 30.7 | 4.8 | (21.3 – 40.1) |
Ohio | 400 | 24.8 | 3.4 | (18.1 – 31.5) |
Oregon | 238 | 32.2 | 5.0 | (22.4 – 42.0) |
Pennsylvania | 206 | 35.0 | 4.6 | (26.0 – 44.0) |
Rhode Island | 181 | 34.0 | 5.2 | (23.8 – 44.2) |
Texas | 207 | 15.9 | 4.3 | (7.5 – 24.3) |
Utah | 342 | 30.5 | 3.4 | (23.8 – 37.2) |
Vermont | 226 | 34.8 | 4.6 | (25.8 – 43.8) |
Wisconsin | 206 | 32.5 | 4.6 | (23.5 – 41.5) |
Puerto Rico | 202 | 14.0 | 2.8 | (8.5 – 19.5) |
31 States / Area | 8,107 | 29.0 | 1.1 | (26.8 – 31.2) |
Median | 30.2 | |||
Range | 14.0-38.8 |
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
± Sample size for adults with current asthma, excludes “DK/Refused”
§ Standard error
† Confidence interval
Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2018/pdf/sdq_report_acbs_18-508.pdfpdf icon
Page last reviewed: October 8, 2021